cbdMD’s Animal Health Brand Paw CBD Earns NASC Quality Seal

“The NASC Quality Seal assures our customers that we want only the best for our pets and customers can trust their pets’ health and wellness to the Paw CBD brand.” said Martin A. Sumichrast, Chairman & co-CEO of cbdMD.

CHARLOTTE, N.C. (PRWEB) August 11, 2021

Paw CBD, a division of cbdMD, Inc. (NYSE American: YCBD, YCBDpA) one of the leading, and most highly trusted and recognized CBD brands, announced today that Paw CBD has received its official certification from the National Animal Supplement Council for its CBD hard chews for dogs and CBD oil tinctures and soft chews for both dogs and cats.

The National Animal Supplement Council (NASC) is a nonprofit group committed to protecting and enhancing the health of companion animals throughout the country. NASC has dedicated itself to safety and quality in the animal supplement space in the United States, identifying and certifying only the best quality products for cats, dogs and horses.

The NASC Quality Seal certifies that a company has successfully passed a comprehensive facility audit, adheres to NASC quality standards, meets label claims and has undergone and passed an independent audit to ensure compliance with NASC rigorous quality system requirements.

“To earn the right to display the NASC Quality Seal, a company must comply with rigorous audit and quality standards, along with regulatory labeling requirements. The NASC Quality Seal assures consumers they are making a great choice for the health of their pets. Paw CBD is dedicated to supporting ongoing efforts for the health and happiness of companion animals, and we welcome Paw CBD as an industry leader committed to quality and integrity. Together we are truly helping shape the foundation of our industry” said Bill Bookout, President of NASC.

“Meeting the requirements to display the NASC Quality Seal on our products is yet another way for us to demonstrate our commitment to current good manufacturing practices at our facilities. The NASC Quality Seal assures our customers that we want only the best for our pets and customers can trust their pets’ health and wellness to the Paw CBD brand. As important, we feel this milestone will play an important factor in product acceptance, as we target larger FDM distribution channels.” said Martin A. Sumichrast, Chairman & co-CEO of cbdMD.

This NASC certification is just one of many ways Paw CBD has committed itself to the highest possible standards for its CBD pet products. cbdMD has also earned NSF Good Manufacturing Practice (GMP) Registration for its manufacturing processes, which includes all Paw CBD products, and has been awarded the US Hemp Authority seal of approval.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and more. Our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD products, please visit http://www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

About Paw CBD

Paw CBD is a nationally recognized pet consumer cannabidiol (CBD) brand, offering 40+ pet consumer products that combine the properties of CBD oil with “animal-approved” flavors like peanut butter, catnip and turkey. Paw CBD is one of the fastest growing brands in the pet CBD space and is proud to partner with Instagram celebrities, such as Nala Cat and the late Lil Bub. To learn more about the comprehensive line of THC-free1 Paw CBD pet products, please visit pawcbd.com or follow Paw CBD on Instagram and Facebook.

1 THC-free is defined as below the level of detection using validated scientific analytical methods.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the “SEC”) on December 22, 2020 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

Company Contact:

John Weston

Director of Investor Relations

john.weston@cbdmd.com

704-249-9515

Share article on social media or email: